Ixazomib citrate
Ixazomib citrate (MLN9708) is an orally administered prodrug that is rapidly hydrolyzed to the active proteasome inhibitor ixazomib. This second-generation inhibitor demonstrates potent antineoplastic activity in vitro and in vivo, primarily applied in multiple myeloma research and investigations of proteasome function.
Product Specifications
CAS Number
1239908-20-3
Product Name Alternative
MLN9708, MLN-9708, MLN 9708, Ixazomib, Ixazomib citrate, Ixazomib Citrate, Inhibitor, inhibit, Autophagy, Proteasome
Field of Research
Cell Biology, Pharmacology & Drug Discovery, Protein Biochemistry
Purity
98.37% (May vary between batches)
Solubility
DMSO:100 mg/mL (193.38 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (7.74 mM)
Smiles
CC (C) C[C@H] (NC (=O) CNC (=O) c1cc (Cl) ccc1Cl) B1OC (=O) C (CC (O) =O) (CC (O) =O) O1
Molecular Formula
C20H23BCl2N2O9
Molecular Weight
517.12
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
